Joselle M. Cook

Featured in: Favicon

nature.com Favicon

wiley.com

mdpi.com

ashpublications.org Favicon

cancernetwork.com Favicon

onlinelibrary.wiley.com

Articles

The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events | Leukemia

Aug 28, 2024 | nature.com | Saurabh Zanwar |Jonas Paludo |Ronald S. Go |Joselle M. Cook |Sikander Ailawadhi |Thomas M Habermann | +10 more

An under-recognized source of bleeding in Waldenström macroglobulinemia (WM) is the development of an acquired von Willebrand syndrome (AVWS) [1]. In WM, the von Willebrand Factor (vWF) glycoprotein can be degraded due to autoantibody destruction, increased shear stress due to hyperviscosity, or sequestered due to adsorption onto malignant cells, leading to the development of AVWS (AVWS-WM) [1, 2].
Toxicity Management in Patients With R/R MM Receiving CAR T-Cell Therapy

Dec 14, 2023 | cancernetwork.com | Carolina Schinke |Joselle M. Cook |Luciano Costa |Binod Dhakal

2 Clarke Drive Cranbury, NJ 08512
Teclistamab plus Nirogacestat in RRMM: The MAJESTEC-2 Study

Nov 20, 2023 | cancernetwork.com | Carolina Schinke |Joselle M. Cook |Luciano Costa |Binod Dhakal

Contemporary ConceptsAwareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored
Talquetamab in RRMM: Results From MonumenTAL-1

Nov 9, 2023 | cancernetwork.com | Carolina Schinke |Joselle M. Cook |Luciano Costa |Binod Dhakal

2 Clarke Drive Cranbury, NJ 08512
Treatment Options for Patients With Relapsed/Refractory Multiple Myeloma (RRMM)

Nov 2, 2023 | cancernetwork.com | Carolina Schinke |Joselle M. Cook |Luciano Costa |Binod Dhakal

Contemporary ConceptsAwareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored
Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma

Aug 14, 2023 | cancernetwork.com | Joselle M. Cook |Matthew James Pianko |Luciano Costa |Timothy Schmidt

As part of a CancerNetwork® Frontline Forum program, Joselle Cook, MBBS; Matthew James Pianko, MD; Luciano Costa, MD, PhD; and Timothy Schmidt, MD, reviewed key data updates and real-world practice findings in newly diagnosed multiple myeloma (NDMM), and how they may impact patient subgroups including those with transplant-ineligible NDMM.
Implementing Real-world Evidence into Clinical Practice in NDMM

Jul 17, 2023 | cancernetwork.com | Joselle M. Cook |Matthew James Pianko

Contemporary ConceptsAwareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored
Goals of Therapy and Treatment Options for Patients with Transplant-Ineligible NDMM

Jun 22, 2023 | cancernetwork.com | Joselle M. Cook |Matthew James Pianko

Contemporary ConceptsAwareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsored